GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Dipna Pharmachem Ltd

Dipna Pharmachem Appoints New Director, Two Directors Resign

MANAGEMENT ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 24 Oct 2026, 04:37 PM IST  ·  BSE ID: 56002ca8-68a0-4741-a6d9-d640ae84adae
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board added a new director and accepted resignations from two existing directors, then updated its audit committee.
🤖 AI Summary
  • Mr. Nirav Madhusudan Soni appointed Additional Non-Executive, Non-Independent Director.
  • Mr. Jitendra Pradipbhai Parmar resigned as Non-Executive, Independent Director.
  • Mr. Manish Shrichand Bachani resigned as Non-Executive, Independent Director.
  • Audit Committee reconstituted effective August 10, 2026, with Mr. Soni as Chair.
  • Resignations confirmed to have no material reasons beyond provided letters.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Director Appointment Effective Date
10th August, 2026
Director Resignation Effective Date
10th August, 2026
🏢 How This Affects the Company
⚙️
Operational Impact
The company's board composition and committee structures have been updated.
⚠️
Risk Impact
The departure of two independent directors and the appointment of a non-independent director alters the board's oversight dynamic.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders should monitor future board and committee activities.
👤
Who Is Affected
All shareholders are affected by changes in the company's board composition and governance structure.
🔍
Management Signal
The appointment of a non-independent director and resignation of independent directors signals a potential shift in board oversight and decision-making dynamics.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Subsequent board meeting minutes for further committee actions.
Disclosure of Mr. Soni's DIN: 08317653 and other director DINs.
Any future announcements regarding the reconstituted Audit Committee's work.
MEDIUM RISK Changes in independent directorships and board composition can impact governance and oversight effectiveness.
💡 Investor Takeaway
Dipna Pharmachem Limited's Board has appointed Mr. Nirav Madhusudan Soni as an Additional Non-Executive, Non-Independent Director and accepted resignations of two Independent Directors, reconstituting the Audit Committee.
❓ Frequently Asked Questions
Who has been appointed as an Additional Director at Dipna Pharmachem?
Mr. Nirav Madhusudan Soni (DIN: 08317653) has been appointed as an Additional Non-Executive and Non-Independent Director.
Which directors have resigned from Dipna Pharmachem?
Mr. Jitendra Pradipbhai Parmar and Mr. Manish Shrichand Bachani have resigned as Non-Executive and Independent Directors.
When were the director changes effective at Dipna Pharmachem?
The appointment and resignations were effective from 10th August, 2026.
Has the Audit Committee of Dipna Pharmachem been reconstituted?
Yes, the Audit Committee has been reconstituted effective 10th August, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.